Ryu Hyeong Ho, Choe Yun Seon, Jo Seongmoon, Youn Jai Il, Jo Seong Jin
Department of Dermatology, Seoul National University Hospital, Seoul, Korea.
J Dermatol. 2014 Jul;41(7):622-7. doi: 10.1111/1346-8138.12541. Epub 2014 Jun 18.
The aim of this study was to investigate the duration of remission periods in psoriasis after narrowband ultraviolet B (NB-UVB) phototherapy, especially during multiple cycles of treatment. We analyzed 63 patients (101 cases) demonstrating marked improvement after NB-UVB phototherapy. The remission period was defined as the duration of time from the end of phototherapy until treatment using either phototherapy or systemic treatments was required again. It was found that an age of 60 years or older, history of systemic therapy within 6 months and three or more phototherapy cycles were significantly associated with shorter remission periods. Furthermore, multivariate analysis confirmed that three or more phototherapy cycles (odds ratio [OR], 4.0; 95% confidence interval [CI], 1.73-9.33; P = 0.001) and a history of systemic therapy (OR, 2.2; 95% CI, 1.27-3.95; P = 0.005) were independently associated with the shorter remission period. In conclusion, when planning NB-UVB phototherapy for psoriatic patients who have undergone multiple phototherapy cycles, clinicians should consider the possibility of shorter remission periods.
本研究的目的是调查窄谱中波紫外线(NB-UVB)光疗后银屑病缓解期的持续时间,尤其是在多个治疗周期期间。我们分析了63例(101例次)接受NB-UVB光疗后有显著改善的患者。缓解期定义为从光疗结束到再次需要使用光疗或全身治疗的时间间隔。结果发现,年龄60岁及以上、6个月内有全身治疗史以及三个或更多光疗周期与较短的缓解期显著相关。此外,多因素分析证实,三个或更多光疗周期(比值比[OR],4.0;95%置信区间[CI],1.73 - 9.33;P = 0.001)和全身治疗史(OR,2.2;95% CI,1.27 - 3.95;P = 0.005)与较短的缓解期独立相关。总之,在为接受过多个光疗周期的银屑病患者规划NB-UVB光疗时,临床医生应考虑缓解期较短的可能性。